A Multicenter Study of Cancer Incidence in CHEK2 1100delC Mutation Carriers: Table 1.-Reference-Cited by-同舟云学术

A Multicenter Study of Cancer Incidence in CHEK2 1100delC Mutation Carriers: Table 1.

Published:2006-12 Issue:12 Volume:15 Page:2542-2545
ISSN:1055-9965
Container-title:Cancer Epidemiology Biomarkers & Prevention
language:en
Short-container-title:Cancer Epidemiol Biomarkers Prev

Author:

Thompson Deborah,Seal Sheila,Schutte Mieke,McGuffog Lesley,Barfoot Rita,Renwick Anthony,Eeles Rosalind,Sodha Nayanta,Houlston Richard,Shanley Susan,Klijn Jan,Wasielewski Marijke,Chang-Claude Jenny,Futreal P. Andrew,Weber Barbara L.,Nathanson Katherine L.,Stratton Michael,Meijers-Heijboer Hanne,Rahman Nazneen,Easton Douglas F.

Publisher

American Association for Cancer Research (AACR)

Subject

Oncology,Epidemiology

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cancer risks for other sites in addition to breast in CHEK2 c.1100delC families;Genetics in Medicine;2024-09

2. Association of the CHEK2 c.1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer‐specific survival;Cancer Medicine;2023-07-03

3. Case report: Tisagenlecleucel for treatment of relapsed B- acute lymphoblastic leukemia in a patient with CHEK2 mutation;Frontiers in Pediatrics;2023-03-01

4. Association of the CHEK2 c.1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer-specific survival;2023-02-13

5. Identification of CHEK2 Germline Mutations in BRCA1/2- and PALB2-Negative Breast and Ovarian Cancer Patients;Human Heredity;2022